Atypical Response in Metastatic Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: Radiographic Patterns and Clinical Value of Local Therapy

SIMPLE SUMMARY: The emergence of atypical response (AR) has challenged the process of response evaluation and the subsequent management of non-small cell lung cancer (NSCLC) patients treated with PD-1/PD-L1 inhibitors. We conducted a multicenter retrospective analysis and found that AR was not an un...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shanshan, Zhang, Jinmeng, Chu, Li, Chu, Xiao, Yang, Xi, Li, Yida, Guo, Tiantian, Zhou, Yue, Xu, Dayu, Mao, Jiuang, Zheng, Zhiqin, An, Yulin, Sun, Hua, Dong, Huiling, Yu, Silai, Ye, Ruiting, Hu, Jie, Chu, Qian, Ni, Jianjiao, Zhu, Zhengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818210/
https://www.ncbi.nlm.nih.gov/pubmed/36612176
http://dx.doi.org/10.3390/cancers15010180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818210/
https://www.ncbi.nlm.nih.gov/pubmed/36612176
http://dx.doi.org/10.3390/cancers15010180

Ejemplares similares